Patrick Honderlick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patrick Honderlick has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- L J Couderc
Service de Pneumologie, Hôpital Foch, Suresnes, France
6 shared publications P Cahen
6 shared publicationsJ. Gravisse
3 shared publications- B. Philippe
Service Pneumologie et Microbiologie, Hôpital Foch
2 shared publications - E. Catherinot
Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes - INSERM U550, Faculté de Médecine Necker, Paris, France
2 shared publications E. Rivaud
2 shared publications
Latest Publications
- 1 January 2013
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 30, A22
Rôle de l’antigène galactomannane dans le lavage broncho-alvéolaire
- 1 January 2013
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 30, A22
Rôle de l’antigène galactomannane dans le lavage broncho-alvéolaire
- Open Access
- 5 November 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 311
Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency
Background: Mycobacterium genavense is a rare nontuberculous mycobacteria (NTM). Human infections are mostly disseminated in the setting of the AIDS epidemic or the use of aggressive immunosuppressive treatments. M. genavense culture is fastidious, requiring supplemented media. Pulmonary involvement rarely occurs as a primary localization. Cases presentation: We report here two patients with pneumonia as the predominant manifestation of M. genavense infection: one kidney transplanted patient and one HIV-infected patient. Both patients were initially treated with anti-tuberculous drugs before the identification of M. genavense on sputum or broncho-alveolar lavage fluid culture. A four-drug regimen including clarithromycin and rifabutin was started. Gamma interferon has been helpful in addition to antimycobacterial treatment for one patient. Conclusion: Clinicians should be aware that M. genavense could be the etiologic agent of sub-acute pneumonia mimicking tuberculosis in patients with cellular immunodeficiency status.
- 5 November 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 311
Open AccessMycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency
Background: Mycobacterium genavense is a rare nontuberculous mycobacteria (NTM). Human infections are mostly disseminated in the setting of the AIDS epidemic or the use of aggressive immunosuppressive treatments. M. genavense culture is fastidious, requiring supplemented media. Pulmonary involvement rarely occurs as a primary localization. Cases presentation: We report here two patients with pneumonia as the predominant manifestation of M. genavense infection: one kidney transplanted patient and one HIV-infected patient. Both patients were initially treated with anti-tuberculous drugs before the identification of M. genavense on sputum or broncho-alveolar lavage fluid culture. A four-drug regimen including clarithromycin and rifabutin was started. Gamma interferon has been helpful in addition to antimycobacterial treatment for one patient. Conclusion: Clinicians should be aware that M. genavense could be the etiologic agent of sub-acute pneumonia mimicking tuberculosis in patients with cellular immunodeficiency status.
- 1 December 2007
- Published by Elsevier in Pathologie Biologie
- Vol. 55 (10) , 531-533
Y a-t-il un changement perceptible dans l'écologie des Candida species responsables de fungémie? Observation de 2000 à 2006 à l'hôpital Foch
- 1 December 2007
- Published by Elsevier in Pathologie Biologie
- Vol. 55 (10) , 531-533
Y a-t-il un changement perceptible dans l'écologie des Candida species responsables de fungémie? Observation de 2000 à 2006 à l'hôpital Foch
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.
- 30 November 2006
- Published by Elsevier in Pathologie Biologie
- Vol. 54 (8-9) , 467-469
La détection par une PCR multiplex de bactéries responsables de pneumopathies atypiques améliore-t-elle les performances du diagnostic microbiologique des infections du tractus respiratoire ?
- 30 November 2006
- Published by Elsevier in Pathologie Biologie
- Vol. 54 (8-9) , 467-469
La détection par une PCR multiplex de bactéries responsables de pneumopathies atypiques améliore-t-elle les performances du diagnostic microbiologique des infections du tractus respiratoire ?
- 1 October 2006
- Published by Elsevier in Pathologie Biologie
- Vol. 54 (8-9) , 462-466
Quelle sensibilité aux antibiotiques pour les bactéries responsables d'infections urinaires ? Que penser de fosfomycine et nitrofuranes ?
- 1 October 2006
- Published by Elsevier in Pathologie Biologie
- Vol. 54 (8-9) , 462-466
Quelle sensibilité aux antibiotiques pour les bactéries responsables d'infections urinaires ? Que penser de fosfomycine et nitrofuranes ?
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 53
Aspergillose pulmonaire du malade non neutropénique et antigénémie aspergillaire
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 53
Aspergillose pulmonaire du malade non neutropénique et antigénémie aspergillaire
- 1 June 2000
- Vol. 48 (5) , 467-9
[Microbiological diagnosis of bacteremia from a catheter: a simple method? Results of a retrospective study].
Diagnosing catheter-related bloodstream infections is important but not always easy and a failure to make the diagnosis may have serious consequences. A high rate of unnecessary catheter removal is noted. We retrospectively compared the clinical and usual methods of microbiological diagnoses of catheter-related sepsis to the speed of detection of the catheter versus peripheral blood cultures using the Bact-Alert system. We analyzed 50 files of patients with central indwelling devices: 16 single lumen catheters and 34 implanted ports. Twenty-one catheters were classified as infected, and we observed an earlier positivity of catheter versus peripheral blood in all cases, but significant for 19 patients. According to standard diagnosis methods, 29 catheters were estimated non-infected, a more rapid detection of peripheral culture was reported for 17 specimens and, for another eight patients, the time of detection was equal to blood culture drawn from the catheter. In this group, four discrepancies were recorded with a differential time in favor of sepsis related to catheters ranging from 0.5 to 2 hours. Because of its simplicity and low cost, we believed that this method could be the first step of a diagnosis of catheter-related sepsis and could, therefore, avoid unjustified removal, in particular for the implanted ports for which the diagnostic methods are less codified than for catheters. A prospective study is ongoing; the design of the study focuses only on implanted ports.
- 1 June 2000
- Vol. 48 (5) , 467-9
[Microbiological diagnosis of bacteremia from a catheter: a simple method? Results of a retrospective study].
Diagnosing catheter-related bloodstream infections is important but not always easy and a failure to make the diagnosis may have serious consequences. A high rate of unnecessary catheter removal is noted. We retrospectively compared the clinical and usual methods of microbiological diagnoses of catheter-related sepsis to the speed of detection of the catheter versus peripheral blood cultures using the Bact-Alert system. We analyzed 50 files of patients with central indwelling devices: 16 single lumen catheters and 34 implanted ports. Twenty-one catheters were classified as infected, and we observed an earlier positivity of catheter versus peripheral blood in all cases, but significant for 19 patients. According to standard diagnosis methods, 29 catheters were estimated non-infected, a more rapid detection of peripheral culture was reported for 17 specimens and, for another eight patients, the time of detection was equal to blood culture drawn from the catheter. In this group, four discrepancies were recorded with a differential time in favor of sepsis related to catheters ranging from 0.5 to 2 hours. Because of its simplicity and low cost, we believed that this method could be the first step of a diagnosis of catheter-related sepsis and could, therefore, avoid unjustified removal, in particular for the implanted ports for which the diagnostic methods are less codified than for catheters. A prospective study is ongoing; the design of the study focuses only on implanted ports.
- 1 June 2000
- Vol. 48 (5) , 470-1
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
From January 1995 to December 1998, 2,912 strains of enteric bacilli were isolated from the urinary tract. Increasing antibiotic resistance in Enterobacteriaceae as a cause of urinary tract infection (UTI) led us to reevaluate first- and second-line therapies. We studied antimicrobial susceptibilities of these strains to norfloxacin (NOR), nalidixic acid (NAL), trimethoprim sulfamethoxazole (TS) and nitrofurantoin (FT) using the disk diffusion method. These results show no significant superiority of the activity of nitrofurantoin against Enterobacteriaceae compared with the other antibiotics with sustained concentration in urine. However, if we consider only multiresistant Enterobacteriaceae (cefotaxime resistant), this molecule appears to be very active. These results show a significant superiority of nitrofurantoin in vitro against these multiresistant Enterobacteriaceae. Thus, this molecule could once again become a good choice for the treatment of uncomplicated UTI.
- 1 June 2000
- Vol. 48 (5) , 470-1
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
From January 1995 to December 1998, 2,912 strains of enteric bacilli were isolated from the urinary tract. Increasing antibiotic resistance in Enterobacteriaceae as a cause of urinary tract infection (UTI) led us to reevaluate first- and second-line therapies. We studied antimicrobial susceptibilities of these strains to norfloxacin (NOR), nalidixic acid (NAL), trimethoprim sulfamethoxazole (TS) and nitrofurantoin (FT) using the disk diffusion method. These results show no significant superiority of the activity of nitrofurantoin against Enterobacteriaceae compared with the other antibiotics with sustained concentration in urine. However, if we consider only multiresistant Enterobacteriaceae (cefotaxime resistant), this molecule appears to be very active. These results show a significant superiority of nitrofurantoin in vitro against these multiresistant Enterobacteriaceae. Thus, this molecule could once again become a good choice for the treatment of uncomplicated UTI.